Cargando…
Primary ovarian cancer chemotherapy: current standards of care
Chemotherapy has been regarded as standard therapy for the majority of women with advanced epithelial ovarian cancer for several decades, with this role filled largely by the alkylating agents — used as monotherapy — until the mid-1980s. The activity of cisplatin in this disorder was established dur...
Autores principales: | McGuire, W P, Markman, M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750616/ https://www.ncbi.nlm.nih.gov/pubmed/14661040 http://dx.doi.org/10.1038/sj.bjc.6601494 |
Ejemplares similares
-
Resistance to chemotherapy in advanced ovarian cancer: mechanisms and current strategies
por: Vasey, P A
Publicado: (2003) -
Intraperitoneal chemotherapy in the management of ovarian cancer: focus on carboplatin
por: Markman, Maurie
Publicado: (2009) -
Current Approaches and Challenges in Managing and Monitoring Treatment Response in Ovarian Cancer
por: Marcus, Charlotte S, et al.
Publicado: (2014) -
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer: Where Do We Go From Here?
por: Markman, Maurie
Publicado: (2016) -
Auditing the diagnosis of cancer in primary care: the experience in Scotland
por: Baughan, P, et al.
Publicado: (2009)